Optic neuropathy in patients with glioblastoma receiving bevacizumab.
about
Two Patients With Brain Tumors Who Received Bevacizumab and Radiotherapy: Optic Neuropathy and Quality-of-Life IssuesSociety for Neuro-Oncology 2014 annual meeting updates on central nervous system metastasesBevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme.Insight into 144 patients with ocular vascular events during VEGF antagonist injectionsPhotopsias during Systemic Bevacizumab TherapyBevacizumab in glioblastoma multiforme.Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.Unexpected late radiation neurotoxicity following bevacizumab use: a case series.In search of a treatment for radiation-induced optic neuropathy.Neuro-ophthalmic side effects of molecularly targeted cancer drugs.Systemic anti-vascular endothelial growth factor therapies induce a painful sensory neuropathy.Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme.Vision loss in glioblastoma: Disease mimicking presumed therapeutic toxicity
P2860
Q26853684-70A85631-A067-4A95-9AA4-1211A3C278AAQ30356590-C8BEC25D-1D3B-46C0-92E9-2CD0155F71CCQ30665022-28E837B1-ABF8-4C33-8274-CF2B6EB51C27Q34412979-D17E4A42-7786-44E3-8264-C182A81C2CBEQ34679133-2036BFBF-0234-4979-8F45-8914559F717CQ35822200-193C721A-3676-4039-B8DD-559C05366393Q36741382-538A6C05-CE27-4EEF-B80B-2FAD225797C9Q37965628-193477E7-E368-43DA-A31F-6BEEF3E34988Q42143173-14C38185-B5EE-4A2D-83F3-3D9BEE56905FQ43446900-E4541466-5990-4D6C-9443-9481F9D2851DQ46196733-2C140FBB-B853-4130-8FE6-5AB83674D6A9Q47625145-CB9D376D-2931-4186-934F-D83F780F9D15Q48460372-80211476-4DBC-4763-B56D-6A887EFD1E9FQ48746366-46FC4D65-C445-4DEF-A8AF-33F353ED4A30Q53788954-D95BC1E4-3CF6-463B-B4BF-156C14FDB136Q58571049-1974533C-3A30-444A-A7E6-EC24108F0012
P2860
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@ast
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@en
type
label
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@ast
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@en
prefLabel
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@ast
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@en
P2093
P2860
P1433
P1476
Optic neuropathy in patients with glioblastoma receiving bevacizumab.
@en
P2093
D G Aregawi
H M Fathallah-Shaykh
J H Sherman
J M Larner
P J Bierman
S A Newman
P2860
P304
P356
10.1212/WNL.0B013E3181C3FD00
P407
P577
2009-12-01T00:00:00Z